This is hard to believe! “Oral ZYVOX® (linezolid) was associated with significant savings to the health care system %u2013 an average of $4,630 per patient %u2013 compared to vancomycin when used in an outpatient setting for people with certain infections, according to data to be presented today at the Infectious Diseases Society of America (IDSA) [...]